Christopher Holden, CEO of AmSurg, sold 3,000 shares of company stock on Feb. 5, according to a WKRB News & Analysis report.
The transaction was disclosed in a filing with the U.S. Securities and Exchanges Commission.
The shares were sold at an average of $40.73 each for a total of $122,190.
Mr. Holden now owns 291,198 company shares, valued an estimated $11,860,495.
More Articles on Transactions and Valuation:
7 Recent Eye Surgery Center Plans, Expansions & Achievements
5 Recent Ambulatory Surgery Center Acquisitions & Partnerships
ASC & Hospital Partnerships: Weighing the Pros & Cons
The transaction was disclosed in a filing with the U.S. Securities and Exchanges Commission.
The shares were sold at an average of $40.73 each for a total of $122,190.
Mr. Holden now owns 291,198 company shares, valued an estimated $11,860,495.
More Articles on Transactions and Valuation:
7 Recent Eye Surgery Center Plans, Expansions & Achievements
5 Recent Ambulatory Surgery Center Acquisitions & Partnerships
ASC & Hospital Partnerships: Weighing the Pros & Cons